Internal Medicine, Hematology & Oncology · Columbia, MO
NPI
1922404367
Since 2014
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
4
Medicare group memberships
Hospitals
4
Hospital affiliations
1 Hospital Dr
Columbia, MO, 65212
Phone (573) 882-8445
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
195 services
Medicare patients, 2024
62
Average age 69
Drug cost, 2024
$2.1M
469 prescriptions
Company payments, 2025
$952
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Arindam Bagchi was code 99214 (office e&m - established), 73 times for 27 patients. In total Arindam Bagchi billed 195 services in 15 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 73 | 27 | $63.98 | $4,671 |
| 99233 Hospital E&M - Subsequent | Facility | 53 | 15 | $85.26 | $4,519 |
| 99215 Office E&M - Established | Facility | 31 | 12 | $87.28 | $2,706 |
By year: 2022 $7,878 for 100 services; 2023 $13K for 159 services; 2024 $15K for 195 services.
Medicare prescription drug claims, 2024
In 2024, the drug Arindam Bagchi prescribed most often to Medicare patients was Anastrozole, with 90 prescriptions and refills. In total Arindam Bagchi wrote 469 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 90 | 205 | 28 | $1,392 |
| Verzenio Abemaciclib | 36 | 36 | Under 11 | $526K |
| Keytruda Pembrolizumab | 30 | 30 | Under 11 | $434K |
| Opdivo Nivolumab | 29 | 29 | Under 11 | $420K |
| Trazimera Trastuzumab-Qyyp | 23 | 23 | Under 11 | $119K |
| Tamoxifen Citrate Generic | 22 | 47 | Under 11 | $924 |
| Oxycodone Hcl Generic | 16 | 16 | Under 11 | $291 |
| Ondansetron Odt Ondansetron | 15 | 15 | Under 11 | $283 |
| Levothyroxine Sodium Generic | 14 | 22 | Under 11 | $91.42 |
| Neulasta Onpro Pegfilgrastim | 11 | 11 | Under 11 | $61K |
Brand drugs: 175 claims; generic drugs: 294 claims; opioid claims: 34.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Arindam Bagchi $952 ($952 in general payments such as food, travel and fees) from 13 companies. The largest payer was Gilead Sciences, Inc. with $196.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 7 | $196 |
| Tempus AI, Inc TEM | 2 | $126 |
| Merck Sharp & Dohme LLC MRK | 4 | $116 |
| Daiichi Sankyo Inc. 4568.T | 4 | $95.53 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $93.54 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $84.01 |
| Pfizer Inc. PFE | 3 | $73.13 |
| Karyopharm Therapeutics Inc. KPTI | 2 | $47.48 |
| Array Biopharma Inc PFE | 2 | $36.4 |
| Janssen Biotech, Inc. JNJ | 2 | $30.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.